首页> 外文期刊>Expert opinion on drug delivery >Novel probiotic dissolvable carboxymethyl cellulose films as oral health biotherapeutics: In vitro preparation and characterization
【24h】

Novel probiotic dissolvable carboxymethyl cellulose films as oral health biotherapeutics: In vitro preparation and characterization

机译:新型益生菌可溶羧甲基纤维素薄膜作为口腔保健生物治疗剂:体外制备和表征

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Objectives: Oral health is influenced by the mouth's resident microorganisms. Dental caries and periodontitis are oral disorders caused by imbalances in the oral microbiota. Probiotics have potential for the prevention and treatment of oral disorders. Current formulations, including supplements and foods, have limitations for oral delivery including short storage time, low residence time in the mouth, effects on food consistency, and low patient compliance. Oral thin films (OTFs) may be efficient in delivering probiotics to the mouth. This research aims to develop a novel carboxymethyl cellulose (CMC)-probiotic-OTF to deliver probiotics for the treatment/prevention of oral disorders. Methods: CMC-OTFs were developed with varying CMC concentration (1.25-10 mg/mL), weight (5-40 g), thickness (16-262 μm), hygroscopicity (30.8-78.9 mg/cm2 film), and dissolving time (135-600 s). The 10 g 5 mg/mL CMC-OTF was selected and used to incorporate Lactobacillus fermentum NCIMB 5221 (6.75 × 108 cells/film), a probiotic with anti-inflammatory potential for periodontitis treatment and capable of inhibiting microorganisms responsible for dental caries and oral candidiasis. Results: The CMC-OTF maintained probiotic viability and antioxidant activity following 150 days of storage with a production of 549.52 ± 26.08 μM Trolox equivalents. Conclusion: This research shows the successful development and characterization of a novel probiotic-CMC-OTF with potential as an oral health biotherapeutic.
机译:目的:口腔健康受口腔中微生物的影响。龋齿和牙周炎是由口腔微生物群失衡引起的口腔疾病。益生菌具有预防和治疗口腔疾病的潜力。当前的制剂,包括补充剂和食物,对于口服递送具有局限性,包括储存时间短,在口腔中停留时间短,对食物稠度的影响以及患者依从性低。口服薄膜(OTF)可能会有效地将益生菌传递到口腔。这项研究旨在开发一种新型的羧甲基纤维素(CMC)-益生菌-OTF,以提供益生菌来治疗/预防口腔疾病。方法:开发CMC-OTF,使其具有不同的CMC浓度(1.25-10 mg / mL),重量(5-40 g),厚度(16-262μm),吸湿性(30.8-78.9 mg / cm2膜)和溶解时间(135-600 s)。选择了10 g 5 mg / mL CMC-OTF,并用于掺入发酵乳杆菌NCIMB 5221(6.75×108个细胞/膜),一种益生菌,对牙周炎具有抗炎作用,能够抑制龋齿和口腔微生物念珠菌病。结果:CMC-OTF在储存150天后保持了益生菌的活力和抗氧化活性,产量为549.52±26.08μMTrolox当量。结论:这项研究表明新型益生菌-CMC-OTF的成功开发和表征具有潜在的口腔健康生物治疗作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号